Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-07

Clinical Trial Results: TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection [NA]

View source ↗

Summary

Study results on rifapentine pharmacokinetics in children undergoing treatment for latent tuberculosis infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • rifapentine (rifapentine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Tuberculosis | NA | Status: COMPLETED | Results posted: 2026-07-07